Dogwood Therapeutics, Inc. Accounts Payable
Dogwood Therapeutics, Inc. (DWTX) had Accounts Payable of $411.52 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $411.52K.
- 2026-03-31: Accounts Payable, Current $144.40K.
- 2025-12-31: Accounts Payable, Current $760.95K.
- 2025-09-30: Accounts Payable, Current $584.60K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $411.52K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $144.40K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $760.95K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $584.60K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $498.12K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.15M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.23M 10-K · filed 2026-03-18 |
| 2024-09-30 | $454.96K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $217.76K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $196.76K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $111.91K 10-K · filed 2025-03-31 |
| 2023-09-30 | $205.37K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $214.31K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $135.09K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $573.16K 10-K/A · filed 2024-03-08 |
| 2022-09-30 | $679.42K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $665.54K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $330.69K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $353.86K 10-K · filed 2023-03-14 |
| 2021-09-30 | $483.50K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $262.59K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $614.66K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $368.90K 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |